+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Contraceptive Devices Market Report and Forecast 2023-2031

  • PDF Icon


  • 140 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5786928
The global contraceptive devices market size attained a value of about USD 10.86 billion in 2022. The market is anticipated to grow further at a CAGR of 6.55% during the forecast period of 2023-2031 to attain a value of USD 19.23 billion by 2031.

Contraceptive Devices Market: Introduction

Contraceptive devices are medical tools, devices, or methods used to prevent pregnancy by blocking or reducing the chances of fertilization or implantation of a fertilized egg. These devices can be used by men or women, and they come in various forms, including hormonal, barrier, intrauterine devices (IUDs), sterilization, and others. Hormonal contraceptive devices contain hormones that prevent ovulation or thicken cervical mucus, making it difficult for sperm to reach the egg. Barrier devices, such as condoms and diaphragms, physically prevent sperm from reaching the egg. IUDs are inserted into the uterus and can prevent fertilization and implantation. Sterilization procedures are permanent and involve blocking or cutting the fallopian tubes in women or vas deferens in men. The choice of contraceptive device depends on various factors such as individual preference, medical history, and lifestyle.

The global contraceptive devices market is a growing industry driven by increasing awareness about birth control, the rising incidence of sexually transmitted infections (STIs), and the need for family planning. The market for contraceptive devices is segmented into various categories such as hormonal, barrier, intrauterine devices (IUDs), sterilization, and others. The hormonal segment is expected to dominate the market during the forecast period due to the high efficacy rate and ease of use of hormonal contraceptives. The intrauterine devices (IUDs) segment is also expected to witness significant growth due to the increasing adoption of long-acting reversible contraceptives (LARC) and the availability of newer and more advanced IUDs in the market.

Geographically, the global contraceptive devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held the largest share of the market in the historical period owing to the high demand for contraceptives and the presence of well-established healthcare infrastructure. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period, owing to the large population base and increasing awareness about birth control.

Contraceptive Devices Market Segmentations

Market Breakup by Product Type

  • Male Contraceptive Devices
  • Condoms
  • Spermicides
  • Female Contraceptive Devices
  • Female Condoms
  • Contraceptive Sponges
  • Contraceptive Vaginal Rings
  • Intrauterine Devices
  • Sub-dermal Contraceptive Implants
  • Non-Surgical Permanent Contraceptive Devices

Market Breakup by Technology

  • Hormonal Contraceptives
  • Barrier Contraceptives

Market Breakup by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Channel
  • Public Channel
  • Others

Contraceptive Devices Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others
Key Developments in the Contraceptive Devices Market
Introduction of long-acting reversible contraceptives (LARC): LARC, such as intrauterine devices (IUDs) and contraceptive implants, are gaining popularity due to their high efficacy rates and convenience of use. Companies are investing in the development of newer and more advanced LARC options to cater to the growing demand.

Increasing focus on male contraception: Male contraception is a largely untapped market, but there is growing interest in the development of new male contraceptive options. Companies are investing in research and development to create safe and effective male contraceptive products.

Growing demand for non-hormonal contraceptive options: Hormonal contraceptives have been the dominant option for birth control for many years, but there is a growing demand for non-hormonal options due to concerns about side effects and health risks. Companies are developing newer non-hormonal contraceptive options such as copper IUDs and fertility tracking devices.

Adoption of digital health technologies: There is a growing trend towards the use of digital health technologies such as mobile apps and wearable devices for birth control and family planning. Companies are developing innovative digital health solutions to cater to this growing demand.

Mergers and acquisitions: The contraceptive devices market is highly competitive, and companies are looking to strengthen their position in the market through mergers and acquisitions. For instance, in 2020, Mylan merged with Pfizer's Upjohn business to create Viatris Inc., a global healthcare company with a diverse portfolio of products including contraceptive devices.

Key Players in the Global Contraceptive Devices Market

The report gives an in-depth analysis of the key players involved in the contraceptive devices market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • Bayer AG
  • Pfizer Inc
  • Janssen Global Services, LLC
  • Teva Pharmaceutical Industries Ltd
  • Merck Sharp & Dohme Corp
  • Mylan N.V
  • Reckitt Benckiser Group plc
  • Veru Inc
  • Medisafe Distribution Inc
  • CooperSurgical, Inc
  • Devex
  • Mayer Laboratories, Inc
  • Allergan plc
  • Agile Therapeutics
  • HLL Lifecare
  • Mankind Pharma
  • TTK HealthCare
  • Boehringer Ingelheim International GmbH
  • V-Care Pharma Pvt. Ltd
  • Cipla Inc.

This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Contraceptive Devices Market Overview
3.1 Global Contraceptive Devices Market Historical Value (2016-2022)
3.2 Global Contraceptive Devices Market Forecast Value (2023-2031)
4 Global Contraceptive Devices Market Landscape
4.1 Global Contraceptive Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Contraceptive Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Distribution Channel
5 Global Contraceptive Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Contraceptive Devices Market Segmentation
6.1 Global Contraceptive Devices Market by Product Type
6.1.1 Market Overview
6.1.2 Male Contraceptive Devices Condoms Spermicides
6.1.3 Female Contraceptive Devices Female Condoms Contraceptive Sponges Contraceptive Vaginal Rings Intrauterine Devices Sub-dermal Contraceptive Implants Non-Surgical Permanent Contraceptive Devices
6.2 Global Contraceptive Devices Market by Technology
6.2.1 Market Overview
6.2.2 Hormonal Contraceptives
6.2.3 Barrier Contraceptives
6.3 Global Contraceptive Devices Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Hospital Pharmacy
6.3.3 Retail Pharmacy
6.3.4 Online Channel
6.3.5 Public Channel
6.3.6 Others
6.4 Global Contraceptive Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Contraceptive Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Contraceptive Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Contraceptive Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Contraceptive Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Contraceptive Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Bayer AG
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Pfizer Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Janssen Global Services, LLC
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Teva Pharmaceutical Industries Ltd.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Merck Sharp & Dohme Corp.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Mylan N.V.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Reckitt Benckiser Group plc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Veru Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Medisafe Distribution Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 CooperSurgical, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Devex
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Mayer Laboratories, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Allergan plc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Agile Therapeutics
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 HLL Lifecare
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Mankind Pharma
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 TTK HealthCare
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
17.19 Boehringer Ingelheim International GmbH.
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisitions
17.19.5 Certifications
17.20 V-Care Pharma Pvt. Ltd.
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisitions
17.20.5 Certifications
17.21.1 Financial Analysis
17.21.2 Product Portfolio
17.21.3 Demographic Reach and Achievements
17.21.4 Mergers and Acquisitions
17.21.5 Certifications
17.22 Cipla Inc.
17.22.1 Financial Analysis
17.22.2 Product Portfolio
17.22.3 Demographic Reach and Achievements
17.22.4 Mergers and Acquisitions
17.22.5 Certifications
18 Global Contraceptive Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Bayer AG
  • Pfizer Inc.
  • Janssen Global Services, LLC
  • Teva Pharmaceutical Industries Ltd.
  • Merck Sharp & Dohme Corp.
  • Mylan N.V.
  • Reckitt Benckiser Group plc.
  • Veru Inc.
  • Medisafe Distribution Inc.
  • Coopersurgical, Inc.
  • Devex
  • Mayer Laboratories, Inc.
  • Allergan plc.
  • Agile Therapeutics
  • Hll Lifecare
  • Ansell Ltd
  • Mankind Pharma
  • Ttk Healthcare
  • Boehringer Ingelheim International Gmbh.
  • V-Care Pharma Pvt. Ltd.
  • Vardhaman Lifecare Pvt Ltd
  • Cipla Inc.



Table Information